Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Two new update entries dated 2026-05-20 and 2026-05-22 were added to the study record's update history. Entries dated 2026-05-06 and 2026-05-07 were removed from the history, altering the visible timeline of recent changes.
    Difference
    0.2%
    Check dated 2026-05-23T09:30:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page records were updated to Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a newer release of the document.
    Difference
    0.1%
    Check dated 2026-05-15T15:47:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The updates log gained two new post dates (May 7 and May 6, 2026) and older dates were removed, altering the sequence of posted information in the study record.
    Difference
    0.2%
    Check dated 2026-05-08T12:23:31.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Two new update dates (2026-04-28 and 2026-04-29) were added to the study's update history. The update entries from 2026-04-07 and 2026-04-08 were removed.
    Difference
    0.2%
    Check dated 2026-05-01T09:12:39.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:40.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:31:39.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.